Company / Shareholders' Equity
CONMED Corporation Shareholders' Equity History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$1.0B
FY2025
5-year range
$745.5M / $1.0B
FY2021-FY2025
Trend
+7.3%
vs FY2024
Sector context
#84 of 160
Health Care
What the data says
At $1.0B, CONMED Corporation's shareholders' equity ranks #84 of 160 in the Health Care sector. Shareholders' Equity has increased for 3 consecutive years, from $746M in FY2022 to $1.0B in FY2025.
Based on SEC 10-K filings.
$1.0B in FY2025 with a 5-year CAGR of +7.8%.
Improved from $834M to $1.0B over the past 2 years.
Health Care sector context is included.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- +11.5%
- 5-Year CAGR
- +7.8%
- 10-Year CAGR
- -
Sector benchmark
#84 of 160 in Health CareTop 52% of 160This company $1.0B Sector average $5.0B
▼
-79.5% below sector average
Key checks
Key Insights
- CONMED Corporation's shareholders' equity has grown for 3 consecutive years.
- 5-year CAGR of +7.8%, indicating consistent growth.
- In FY2025, shareholders' equity increased 7.3% year-over-year.
- Ranks #84 out of 160 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.0B | +7.3% |
| FY2024 | $962.7M | +15.4% |
| FY2023 | $834.2M | +11.9% |
| FY2022 | $745.5M | -5.1% |
| FY2021 | $785.4M | +10.8% |
| FY2020 | $709.0M | -0.2% |
| FY2019 | $710.5M | +7.3% |
| FY2018 | $662.3M | +4.9% |
| FY2017 | $631.4M | +8.8% |
| FY2016 | $580.6M | -0.8% |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026